Reid Hutchins Overview
- Firm
- Advantage Capita...
- Primary Position
-
Managing Directo...
- Primary Industry
-
Information Technology
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Reid Hutchins General Information
Biography
Mr. Reid Hutchins serves as Managing Director at Advantage Capital. He also serves as Board Observer at Recursion Pharmaceuticals. He manages Advantage Capital Partners' New York investment portfolio. His responsibilities include sourcing and structuring new investments, as well as working with current portfolio companies. Prior to joining Advantage Capital in 2006, Mr. Hutchins served as a product development engineer for Advanced Micro Devices and as an engineer and manager with IBM Microelectronics. He brings operational experience in semiconductor design, manufacturing, test and production to the firm. Mr. Hutchins currently sits on the Board of Directors for the Upstate Venture Association of New York (UVANY). He also serves as a member of the Board of Trustees for the Make-A-Wish Foundation® of Northeast New York. Mr. Hutchins holds a bachelor's degree in physics from St. Lawrence University. He also holds a bachelor's degree in electrical engineering and a master's in engineering management from Dartmouth College.
Contact Information
Address
- 80 South Main Street
- Suite 201
- Hanover, NH 03755
- United States
Reid Hutchins Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Advantage Capital | Investor | Managing Director | Saint Louis, MO | PE/Buyout |
Reid Hutchins Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Knoa | Business/Productivity Software | Privately Held (backing) | Venture Capital-Backed | New York, NY | |
Recursion Pharmaceuticals | Drug Discovery | Publicly Held | Formerly VC-backed | Salt Lake City, UT |
Reid Hutchins Lead Partner on Deals (7)
Reid Hutchins has been the lead partner on 7 deals. Their latest deal was with Recursion Pharmaceuticals, a drug discovery company. The deal was made for on 11-Nov-2020.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Recursion Pharmaceuticals | 11-Nov-2020 | Later Stage VC (Series D) | Completed | Drug Discovery | Salt Lake City, UT | |
Recursion Pharmaceuticals | 03-Oct-2017 | Completed | Drug Discovery | Salt Lake City, UT | ||
Grainful | 13-Jun-2017 | Completed | Food Products | Ithaca, NY | ||
Recursion Pharmaceuticals | 07-Feb-2017 | Completed | Drug Discovery | Salt Lake City, UT | ||
Knoa | 27-Jun-2014 | Completed | Business/Productivity Software | New York, NY | ||
Knoa | 03-Dec-2012 | Later Stage VC (Series A1) | Completed | Business/Productivity Software | New York, NY | |
BinOptics | 15-Dec-2011 | Later Stage VC | Completed | Fiberoptic Equipment | Ithaca, NY |
Reid Hutchins Network (101)
Board Members (21)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Kenneth Mabbs Ph.D | Knoa | FA Technology Ventures | New York, NY | |
Zavain Dar | Recursion Pharmaceuticals | Lux Capital | Salt Lake City, UT | |
Recursion Pharmaceuticals | Obvious Ventures | Salt Lake City, UT | ||
Recursion Pharmaceuticals | The Goldman Sachs Group | Salt Lake City, UT | ||
Recursion Pharmaceuticals | Recursion Pharmaceuticals | Salt Lake City, UT |
Portfolio Executives (70)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Sharathchandra Hegde | Recursion Pharmaceuticals | Chief Scientific Officer | 11-Nov-2020 | Salt Lake City, UT |
Ramona Doyle MD | Recursion Pharmaceuticals | Chief Medical Officer | 11-Nov-2020 | Salt Lake City, UT |
Recursion Pharmaceuticals | Vice President, Technical Operations | 11-Nov-2020 | Salt Lake City, UT | |
Recursion Pharmaceuticals | Chief Operating Officer, Operations & President | 11-Nov-2020 | Salt Lake City, UT | |
Recursion Pharmaceuticals | Chief Operating Officer, Operations & President | 11-Nov-2020 | Salt Lake City, UT |
Fund Team Members (10)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Keith Freeman | Advantage Capital | Advantage Capital Solar Partners I | Saint Louis, MO |
Christopher Harris | Advantage Capital | Advantage Capital Community Development Fund 2010 | Saint Louis, MO |
Advantage Capital | Saint Louis, MO | ||
Advantage Capital | Saint Louis, MO | ||
Advantage Capital | Saint Louis, MO |
Reid Hutchins Affiliated Funds (4)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Advantage Capital Solar Partners I | Advantage Capital | Infrastructure Core | Closed | 2018 | ||||
Advantage Capital Community Development Fund 2010 | Advantage Capital | Venture - General | Closed | 2010 | ||||
Advantage Capital Agribusiness Partners | Advantage Capital | Agriculture | Closed | 2014 | ||||
Advantage Capital Partners Illinois Fund I | Advantage Capital | Venture - General | Closed | 2009 |
Reid Hutchins FAQs
-
Who is Reid Hutchins?
Mr. Reid Hutchins serves as Managing Director at Advantage Capital.
-
How much does Reid Hutchins typically invest?
Reid Hutchins's median deal size is
. -
What is Reid Hutchins’s main position?
Reid Hutchins’s primary position is Managing Director.
-
What are the contact details for Reid Hutchins?
Reid Hutchins’s email address is rh
and his phone number is +1 (603) . -
How many active board seats does Reid Hutchins hold?
Reid Hutchins holds 2 board seats including Knoa and Recursion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »